Experts informed about the new fact, that concerns Kazakhstan in the Customs union.
Kazakhstan as one of the participants of the Customs Union may be excluded from the competition between russian and belarusian manufacturers, that concerns national orders for medicines.
The Ministry of Industry prepared a project established by the Government of the Russian Federation and introduced additional requirements for participants of national orders for medicine. One of these requirements iclude recommending in orders of medicines, russian or belarusian origin. Whereas medicines from Kazakhstan were not mentioned in this project. Eurasian Economic Commission considers that a project has been prepared properly.
According to the sources from the Commission, each country should ensure so- called National systems of production. At the moment, Russia and Belarus ensured it, while Kazakhstan still hasn't done this. In all three countries there isn't any common technical regulation on the pharmaceutical market. The pharmaceutical market of Kazakhstan has been still increasing, however the representatives of the country lately hasn't taken part in any of appointments, that concerned sales market of pharmaceutics.
However, excluding Kazakhstan according to David Melik-Guseinov is discriminatory and damaging for health service, as Russian and Belarusian companies are not able to produce sufficient amount of medicines. The expert added, that relegating Kazakhstan is a breach of contract of the Customs Union.
While the pharmaceutical industry has been attracting significant investments. For instance Polpharma bought out the joint-stock company of Kazakhstan "HIMFARM" for $ 85 billion, while between Global Pharm of Kazakhstan and turkish Abdi Ibrahim was signed an agreement on building a factory, that is worth $ 60 billion.
Detailed inquiry for
If you have more questions about CUTR certificate, please complete
Our experts will help to solve your problems with pleasure.